Recent events
Recent events tied to this brand in public sources.
Back to profile2 entries
2020
VALBIOTIS publishes 2019 annual results
VALBIOTIS published its 2019 annual results, reporting a net loss of €5.504 million and cash of €8.033 million at year end.
2020
VALBIOTIS and Nestlé Health Science sign TOTUM-63 partnership
VALBIOTIS announced that it had signed a global strategic partnership with Nestlé Health Science to develop and commercialize TOTUM-63. The agreement grants Nestlé Health Science exclusive global commercial rights in the prediabetes and Type 2 Diabetes market and includes payments, royalties, and supply of TOTUM-63.